Next Article in Journal
Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients
Next Article in Special Issue
The Proteome and Citrullinome of Hippoglossus hippoglossus Extracellular Vesicles—Novel Insights into Roles of the Serum Secretome in Immune, Gene Regulatory and Metabolic Pathways
Previous Article in Journal
EcDBS1R4, an Antimicrobial Peptide Effective against Escherichia coli with In Vitro Fusogenic Ability
Previous Article in Special Issue
Comparative Lipidomic Analysis of Extracellular Vesicles Derived from Lactobacillus plantarum APsulloc 331261 Living in Green Tea Leaves Using Liquid Chromatography-Mass Spectrometry
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of Exosomal Epigenetic Modifiers in Cell Communication and Fertility of Dairy Cows

by
Pevindu Abeysinghe
,
Natalie Turner
,
Isabella Morean Garcia
,
Eman Mosaad
,
Hassendrini N. Peiris
and
Murray D. Mitchell
*
Institute of Health and Biomedical Innovation—Centre for Children’s Health Research, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4029, Australia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(23), 9106; https://doi.org/10.3390/ijms21239106
Submission received: 17 November 2020 / Revised: 27 November 2020 / Accepted: 27 November 2020 / Published: 30 November 2020
(This article belongs to the Special Issue Extracellular Vesicles in Phylogeny)

Abstract

:
Abnormal uterine function affects conception rate and embryo development, thereby leading to poor fertility and reproduction failure. Exosomes are a nanosized subclass of extracellular vesicles (EV) that have important functions as intercellular communicators. They contain and carry transferable bioactive substances including micro RNA (miRNA) for target cells. Elements of the cargo can provide epigenetic modifications of the recipient cells and may have crucial roles in mechanisms of reproduction. The dairy industry accounts for a substantial portion of the economy of many agricultural countries. Exosomes can enhance the expression of inflammatory mediators in the endometrium, which contribute to various inflammatory diseases in transition dairy cows. This results in reduced fertility which leads to reduced milk production and increased cow maintenance costs. Thus, gaining a clear knowledge of exosomal epigenetic modifiers is critical to improving the breeding success and profitability of dairy farms. This review provides a brief overview of how exosomal miRNA contributes to inflammatory diseases and hence to poor fertility, particularly in dairy cows.

1. Introduction

Poor reproductive efficiency is directly linked with metabolic disorders, a decline in longevity, reduced milk production, greater involuntary culling rate, and higher cow maintenance rates [1]. Dairy cow fertility has declined as a result of selective breeding for elevated milk production without having due consideration for the functional traits responsible for fertility and reproduction [2]. In addition, an activated inflammatory system via immune and/or infectious challenge of the uterus occurring during the postpartum period and higher metabolic pressure due to elevated milk production [3,4,5] can lead to impaired reproduction and fertilization failure [6]. The establishment of successful pregnancies within short calving intervals is a critical factor for cow management systems and the dairy industry [7]. The cumulative effect of these several adverse factors is decreased profitability of the dairy industry [8].
Fertility affects the biomolecules transferred within the body engulfed in exosomes [9,10]. A greater understanding of the role of exosomes as intercellular signaling vesicles in the last decade has resulted in a paradigm shift in our knowledge of how cells communicate [9,10,11,12,13,14,15]. Exosomes can package, carry and deliver their cargo which includes miRNAs [16], messenger RNAs (mRNA) [16], lipids [17] and proteins [18]. Fluorescently labelled bovine milk-derived exosomes given to mice have been observed to travel throughout the body including to the liver, lung, pancreas, kidney, spleen, colon, brain and the ovaries when administered orally or intravenously [19]. Moreover, exosomes are known to be involved in the communications between maternal and fetal tissues which supports the view that exosomes have a role in supporting reproduction/pregnancy [20].
The early lactation period has been identified as a time of great metabolic stress for the animal and susceptibility to all forms of the disease occurs during this time [21]. Inflammation is defined as a specific or non-specific immune response to tissue damage or invasion by a foreign body [22,23]. Inflammatory mediators have the potential to deteriorate natural endocrinological pathways and cause fertility disorders [24]. Collectively, inflammatory diseases related to the intrauterine environment of dairy cows and those occurring during the early lactation period negatively influence the reproductive cycle and reduce overall fertility [25,26,27].

2. Exosomes

Extracellular vesicles were first detected in plasma as procoagulant platelet-derived particles in 1946 [28] and in later years exosomes have been referred to as “platelet dust” [29]. Under the electron microscope, exosomes in solution appear as spheroids but after drying artificially during preparation, canonical exosomes look more biconcave or cup-like in shape [30]. Exosomes are considered as having a size of 30–120 nm [31,32] differentiating them from microvesicles sized from 100–1000 nm [33] with densities of 1.25 g/mL to 1.30 g/mL [34]. Therefore, physically exosomes separate themselves from other vesicular bodies because of their comparatively smaller size and unified shape.
The bilipid layer of an exosome is rigid [35] and the composition of cholesterol and sphingolipids differ from its parental cell membrane [17]. Exosomes can withstand severe external conditions like low pH, boiling and freezing temperatures [36]. Additionally, exosomes are known to successfully resist the harsh acidic gastrointestinal conditions. Together these factors support the ability and usefulness of exosomes as transport mechanisms in delivering their cargo including miRNA throughout the body and in the circulatory systems of humans and cows [37].

2.1. Exosome Formation & Cargo Sorting Mechanism

The generation of exosomes begins as an inward budding of late endosomes from the multivesicular body (MVB) membrane in which the endosomes later form into an intraluminal vesicle (ILV) [38] and then release of ILVs into extracellular space as exosomes after fusion with the plasma membrane [39]. Importantly, the incorporation of exosomal cargo and cytosolic elements into pre exosomal bodies happens during the formation of ILVs within MVBs. While some ILVs fuse with plasma membranes to produce exosomes, alternatively the rest of ILVs pass through a degradation pathway within lysosomes [33].
There are two suggested mechanisms for the sorting of exosomal cargo into MVBs. One is through an endosomal sorting complex required for transportation (ESCRT) protein machinery which involves four separate proteins ESCRTs (ESCRT-0 to ESCRT-3) [40]. This mechanism cooperates to form MVBs, budding vesicles and sort protein cargo collectively [40,41]. Nonetheless, the exosomal protein “Alix”, has been found in endosomal membrane budding, abscission and exosomal cargo selection processes through syndecan interaction [42].
Alternatively, there has been suggested another exosomal cargo sorting pathway which is ESCRT-independent [33]. It involves raft-based microdomains that segregate cargo laterally inside the endosomal membrane [33]. The microdomains are believed to contain sphingomyelinases in high amounts which produce ceramides through hydrolytic removal of phosphocholine moiety from sphingomyelin [43].
It has been reported that tetraspanin proteins are also involved in exosome biogenesis in protein loading mechanisms. Ubiquitous specialized membrane platform known as Tetraspanin-enriched microdomain (TEM) involves sorting receptors and signaling proteins into compartments in the plasma membrane [44] and that along with TEM, tetraspanin CD81 is involved in trafficking target receptors in the direction of exosomes [45].

2.2. Function of Exosomes

Normally gap junctions, cell surface protein/protein interactions, soluble secreted factors like hormones or cytokines are used as cell communicators for signal transduction purposes [33]. Additionally, nucleotides, lipids or short proteins are involved as electrical and chemical signal propagators from cell to cell [46,47]. The ability of exosomes to communicate between cells is evidenced by observations of exosomes from parental cells interacting with the target cells and influencing the behavior and the phenotypic features of the target cells [47]. Exosomes can successfully deliver genetic materials to the target cells through receptor-ligand interactions, the direct fusion of membranes or internalization through endocytosis [48]. Thus exosomes as a mode of intercellular communication [33] are associated with major cellular processes such as immune responses [49], signal transduction [50] and antigen presentation [51].
After exosomes enter the target cell, fusion with endosomes enables the horizontal genetic transfer of exosomal cargo to the cytoplasm of the target cell [33]. Bioactive components in exosomal cargo have three pathways (1) connect with surface-bound ligands to stimulate target cells directly (2) transfer their cargo to recipient cells via activated receptors (3) epigenetic reprogramming through miRNA, lipids and functional proteins [52].
The functional activity of exosomes differs depending on the originating/parental cell type and the cell’s current fate (i.e., differentiated, stimulated, transformed or stressed), therefore, exosomal cargo also differs [33]. This can then be utilized to gather prognostic information on various diseases [33]. Examples of the use of exosomes in this manner can be seen in cardiovascular and renal diseases [53], lipid metabolic diseases [54], tumor metastasis and angiogenesis [50,55], signal transduction in neurodegenerative disease [56] and chronic inflammation [56].
Exosomes also have key regulatory functions in the immune system including antigen presentation [57], immune suppression [58,59,60] and activation [61]. An example of this was described when exosomes were found to drive apoptosis via the antigen-specific pathway for Dendritic Cell (DC) mediated T cell silencing [62]. Furthermore, immune suppression and T-helper cell type 1 (Th1) immune response inhibition has also been reported by regulatory T cell-secreted exosomes which contain Let-7b, Let-7d, and microRNA-155 as exosomal cargo [58].
As mentioned earlier, exosomal cargo is a reflection of the physiological status of the secreting tissue. Therefore, the differential expression of exosomal cargo between high- and low-fertility dairy cows is now gaining great attention in the research field [15]. This may lead to novel discoveries that can be the building blocks of new prognostic and/or diagnostic tools to predict dairy cow fertility [15].

3. Exosomal Epigenetic Modifiers

Exosomes carry complex functional molecules ranging from proteins [18], lipids [17], mRNAs [16] to miRNAs [16]. Exosomes in dairy cows with uterine infections contain more proteins involved in immune system processes than in non-infected dairy cows [32]. Exosomal proteins have been isolated from non-invasive biofluids such as blood plasma [10,14,32], saliva [63,64] and urine [63]. Therefore proteomic content in exosomes is referred to as indicators of disease status [10,65]. Exosomal lipoprotein has been identified as a potential biomarker [66]. Lipidomic analysis has been shown that exosomal phospholipids may have the potential to change the bovine embryonic phospholipid composition in vitro [67]. Exosomal RNA regulate the genome epigenetically, and is thus regarded as the key biomolecule present within an exosome [68]. It has been reported that DNA is not among the exosomal cargo but a considerable amount of RNA has been detected in exosomes isolated from the mast-cell line (MC/9), primary bone marrow-derived mast cells (BMMC) and a human mast-cell line (HMC-1) [69].
In the following sections, we will focus on the epigenetic molecules that can be carried within exosomes.

3.1. Exosomal mRNA

Milk exosomal mRNAs are involved in metabolic, degradation and signaling pathways [70,71]. Bovine milk-derived exosomal mRNA affects important physiological and immunological functions on human cells in vitro [72]. A recent report proposes the prediction of clinical stages of bovine leukemia virus (BLV) using mRNA profile from bovine milk EVs [70].

3.2. Exosomal Non-Coding RNA

Almost 80% of the transcribed genes of the mammalian genome are non-coding [73,74]. Non-coding RNAs can be categorized into long non-coding RNAs (lncRNA; >200 nucleotides) [75] and miRNA (19–24 nucleotides) [74]. Non-coding RNA regulates the expression level of their target DNA, RNA or protein molecules through various mechanisms such as epigenetic, transcription, post-transcriptional regulations [76]. Stress or disease status triggers aberrant expression of non-coding RNA and that allows the use of non-coding RNAs as specific biomarkers to predict various pathologies [77].

3.2.1. Exosomal Long Non-Coding RNA

A very small number of studies cover research on exosomal lncRNA related to fertility. But a recent study on bovine milk exosome-derived lncRNA has been reported a profile of lncRNAs involve in immunity, development and reproduction [78]. Nonetheless, exosomal lncRNA shows stability in the human digestive system and in harsh environmental conditions in vitro [78]. However, so far miRNA is so far regarded as the main regulatory molecule within exosomal cargo [68].

3.2.2. Exosomal miRNA

Exosomal miRNA plays a vital role in inter-cellular and inter-organism level signal transduction. MiRNAs are theorized to act as an epigenetic regulators acting on approximately 60% of all mammalian genomes. [74,79,80]. They are complementary to the mRNAs 3’ untranslated region (3’ UTR) of its target [79]. Their interactions lead to the inhibition of translation and less frequently leads to mRNA degradation [79]. The miRNAs found in the exosomes are reported to have multiple functions; for example, mir-1 is involved in cardiomyocyte differentiation and proliferation [81], miR-17 is upregulated in B-cell lymphoma [82], miR-181 is involved in hematopoietic cell differentiation [83] and miR-375 is responsible for insulin secretion [84]. Together these findings suggest the extensive regulatory capacity of miRNAs when coupled to the intercellular communication abilities of an exosome [69].
Bovine milk contains high amounts of exosomes and the exosomal cargo contents include biologically active molecules [85,86]. The miRNA content from cow milk-derived EVs shows a great diversity [86]. Therefore, milk exosomal contents can utilize as prognostic biomarkers for many infectious diseases [70]. A considerable number of exosomal miRNAs are contain in bovine milk with great stability [85]. This is evidenced by observation of a non-affected total RNA yield after the acidification of bovine milk [87] and microwave heating only depleting 40% of miRNA-29b but not affecting the yield of miRNA-200c [88]. Ultrasonication of bovine colostrum exosomes resulted in the inhibition of immune regulating function suggesting that the integrity of the exosomal membrane is vital for modulating exosomal miRNA function [89]. Moreover, miRNA are reported to be stable with effective retrieval and analysis of miRNAs possible from formalin-fixed paraffin-embedded tissues [90,91]. Other processing practices of bovine skim milk resulted in variations in miRNA quantity e.g., pasteurization and homogenization were also observed to result in a dramatic loss of miRNA [88] and fermentation resulting in alterations to exosome and miRNA number [92]. An additional benefit of milk exosomes is its ability to be tolerated across species [19]. Bovine milk exosomes loaded with chemotherapeutic and chemopreventive agents have shown higher efficacy against lung tumor xenografts in vivo [19]. Thus, there is potential to utilize these milk exosomes as a vehicle for drug delivery [19].
Exosomal miRNAs show a higher resistance to adverse external conditions [85]. This suggests exosomes may play a key role in the horizontal transfer of miRNA by protecting the miRNAs within their plasma membrane [85,93]. The biosynthesis of exosomal miRNA packaging and communication between cells is illustrated in Figure 1.

Circulating miRNA vs. Exosomal miRNA

It has been reported that the miRNAs present within exosomes were different from the miRNA content of the cell which infers that certain miRNAs are packaged into the exosomes in a unique selective way [69]. A circulating miRNA array profiling serum revealed differentially regulated miRNAs opening up the possibility of these miRNAs as potential therapeutic biomarkers easily accessible from non-invasive, readily available body fluids [94]. In fact, it has been shown that miR-17-5p, miR-20a and miR-22 are downregulated in plasma samples from patients with endometriosis [95]. We have shown that bovine endometrial cells decreased their production of prostaglandin E2 (PGE2) following treatment with exosomes loaded with miRNA-143 (which is a known inhibitor of cyclooxygenase-2 (COX-2), an enzyme required for the production of PGE2) [96]. This effect was reversed by an antagonist of miRNA-143 [96]. The association of miRNAs in inflammation-related diseases has also been reported. Mir-483-5p competitively binds to the 3’ UTR of mRNA Insulin-like growth factor 2 (IGF2) in ovarian endometriosis patients which results in the overgrowth of the endometrial tissue outside the uterus [97]. In a cohort of ovarian endometriosis patients’, 107 miRNAs and 6112 mRNAs were identified [98]. These studies provide support for the use of miRNAs from easily accessible, non-invasive body fluids such as milk, saliva, blood plasma as diagnostic biomarkers and/or the potential to develop/target them into therapeutics which can be used to treat health disorders.

4. Exosomal Epigenetic Modifiers and Fertility

Biological factors such as mRNA/protein abundance and turnover can influence the differential expression of inflammatory mediator genes [99,100]. Cytokine mRNAs including interleukin-8 (IL-8), interleukin-1-beta (IL-1β) have been expressed differentially and influence cytokine response in cervicovaginal epithelial cells [101]. A recent study shows that circulating exosomes from low fertile groups alter the expression of inflammatory mediators responsible for aberrant endometrial inflammation in bovine endometrial epithelial (bEEL) and stromal (bCSC) cells [9]. Figure 2 shows elevated expression of interleukin 1 alpha (IL1α), (C-X-C motif) ligand 8/interleukin -8 (CXCL8/IL8, prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF) in cells with low fertility exosomes [9]. Increased chemokine and cytokine production results in poor endometrial function which in turn negatively affects fertility and pregnancy success [9,102].
The relationships between miRNA and fertility have been revealed recently exposing the severity of the epigenetic behavior of miRNA in exosomal cargo [103]. Higher expression of miR-145 has been identified in recurrent implantation failure (RIF) patients [103]. This miRNA is suggested to target the sequence of mRNA coding the insulin-like growth factor 1 receptor (IGF1R) gene, which is a gene activated in the adhesion of the embryo to endometrial tissue [103]. It has been found that in a mouse model, miR-199a represses the expression of integral transmembrane mucin glycopeptide Mucin 1, which plays a key role in embryo attachment enabling successful implantation [104]. In the cow exosome miRNA derived from uterine fluids of dairy cows with uterine inflammatory diseases has shown a differentially expressed miRNAs than the healthy controls, and, the report has predicted that exosomal miRNA may affect the fertility within the herd [105]. Therefore, exosomal miRNAs have a potential role as an epigenetic regulator of biological signaling pathways of the reproductive cycle during pregnancy (Figure 3) [106].

DNA Methylation and Histone Acetylation

DNA modifications in the exosomal cargo and the consequent epigenetic modification are responsible for tumor progression [109,110,111]. Tumor regulating exosomal miR-652-5p has shown a high level of upstream DNA hypermethylation in tumor tissues and serum samples of oesophageal squamous cell carcinoma (OSCC) [109]. DNA methylation BarH-like 2 homeobox protein (BARHL2) in exosomal DNA from gastric juice has been recently established as a biomarker to predict gastric cancer [112]. Hypermethylation in the tumor suppressor genes P53 and RIZ1 were observed in cells co-incubated with leukemia-derived microvesicles [113]. Level of promotor methylation to mRNA of O6-methylguanine DNA methyltransferase (MGMT) changed during drug treatment to glioblastoma patients [114]. Thus, exosomes transmit information involved in methylation to the recipient cells, ultimately inducing tumor-related microenvironments [111].
Apart from exosomal cargo, modifications to the structure of the DNA and histone proteins regulate fertility [115,116]. Genes with conserved non-methylated promoters are involved in embryo development in bovine species [117]. Recently, the degree of methylation in the promoter region of Bovine Vasa Homology (Bvh) gene has been reported to be higher in dairy bulls with poor sperm motility [118]. It has been shown that DNA hypermethylation disrupts P-element induced wimpy testis (PIWI)-interacting RNA (piRNAs) production which causes hybrid male sterility (HMS) [119]. The cytosine-guanine dinucleotides islands (CpG island) have been reported differentially methylated between high and low motile Bos taurus sperm populations [120]. DNA methylation has been induced as a result of exposure to toxins. For example, chlorpyrifos (CPF) an organophosphate pesticide, alters sporadic methylation levels in male gametes in vitro [116]. Similar DNA methylation patterns have been shown between bovine blastocytes and gametes from various in vitro conditions in a recent study to demonstrate parental effects on epigenetic programming [121]. Identification of methylation signatures in non-small cell lung cancer (NSCLC) showcases the potential of DNA methylation as a prognostic tool [122].
Bioinformatic analysis has shown histone acetylation gene overlap between exosomal mRNA and proteins in transgenerational epigenetic inheritance [123]. An oligodendroglioma cell line has released extracellular vesicles with differentiation-specific linker histone H1˚ [124] which was associated with terminal differentiation [125].
Non-exosomal epigenetic modification (especially acetylation) in histone affects embryo implantation and spermatogenesis [126,127]. It has been demonstrated that the expression of sperm hyperacetylated histone 4 (H4) was reduced in low fertility bulls which results in loose chromatin structures [126]. Abnormal acetylation and methylation in histone three lysine 27 (H3K27) in bovine spermatozoa disrupt activation after fertilization [128]. Metabolic disturbances such as ketone body β-hydroxybutyrate (BOHB) has been demonstrated as an inhibitor of H3K27 and hyperacetylation [129]. Histone deacetylases (NIHDAC) play an important role in female fertility by regulating ovary maturation or ovipositor development [130]. Loss of histone acetylation inhibits chromatin accessibility and nucleosome eviction during spermiogenesis which leads to poor fertility in males [131]. Exposure to toxins such as arsenite has been reported to induce ubiquitination and acetylation of histone which associate with male infertility [132]. Histone acetylation and DNA methylation caused by addictive stimulants (for example, cocaine) have resulted in poor reproductive function in male mice [133]. Nonetheless, post-translational modifications are significant for the fertility and function of seminal proteins in mature sperm [134]. Histone modifications can be utilized to distinguish between aberrant clinical conditions [135].

5. Conclusions

Inflammation in the reproduction tract alters the natural reproductive cycle and ultimately diminishes the potential fertility and pregnancy success of a dairy cow. Additionally, dairy cows suffer from common postpartum uterine inflammatory diseases, e.g., mastitis, metritis and endometritis. These diseases affect dairy cow management by requiring additional labor and financial resources to maintain, treat or cull animals. Exosomes offer a potential method for the evaluation and diagnosis of inflammatory, reproductive and fertility disorders through exosomal content characterization and comparison. Moreover, the ability of exosomes to transport biological molecules including miRNA (i.e., critical epigenetic regulator) could be manipulated as a method for the delivery of therapeutic agents to alter cellular pathways for the benefit of a dairy cow’s reproductive health. So far, successful isolation techniques of miRNA from exosomes are being explored. However, the diagnostic and therapeutic potential of exosomal miRNA to improve bovine fertility is yet to be explored fully.

Author Contributions

Conceptualization, P.A., E.M., H.N.P. and M.D.M.; investigation, P.A.; writing—original draft preparation, P.A.; writing—review and editing, E.M., H.N.P., N.T. and M.D.M.; visualization, P.A. and I.M.G.; supervision, H.N.P., E.M. and M.D.M. All authors have read and agreed to the published version of the manuscript.

Funding

PA is supported by a student scholarship from the Australian Research Council (Grant No: ARC LP160101854) and QUT HDR Tuition fee sponsorship. Our laboratory experiments were funded, in part, by funding from a partnership fund (DRCX1302) between the New Zealand Ministry of Business, Innovation and Employment and New Zealand dairy farmers through DairyNZ Inc.

Acknowledgments

PA is supported by a student scholarship from the Australian Research Council (Grant No: ARC LP160101854) and QUT HDR Tuition fee sponsorship. Our laboratory experiments were funded, in part, by funding from a partnership fund (DRCX1302) between the New Zealand Ministry of Business, Innovation and Employment and New Zealand dairy farmers through DairyNZ Inc.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

BARHL2BarH-like 2 homeobox protein
bCSCBovine endometrial stromal
bEELBovine endometrial epithelial
BLVBovine leukemia virus
BOHBBody β-hydroxybutyrate
BvhBovine Vasa Homology
BMMCBone marrow-derived mast cells
CD4+Cluster of differentiation—4
CD81Cluster of differentiation—81
COX-2Cyclooxygenase-2
CPFChlorpyrifos
CpG islandCytosine-guanine dinucleotides islands
CXCL8/IL8C-X-C chemokine ligand 8/Interleukin 8
CXCL9(C-X-C motif) ligand 9
CXCL10(C-X-C motif) ligand 10
DCDendritic cells
ESCRTEndosomal sorting complex required for transportation
EVExtraccellular vesicles
H3K27Histone three lysine 27
H4Hyperacetylated histone 4
HMC-1human mast-cell line
IGF2Insulin-like growth factor 2
IGF1RInsulin like growth factor 1 receptor
IL1αInterleukin 1—alpha
IL-4Interleukin—4
ILVIntraluminal Vesicles
Let-7bLethal—7b
Let-7dLethal—7d
LHLuteinizing hormone
lncRNALong non-coding RNA
MC/9Mast-cell line/9
MGMTO6-methylguanine DNA methyltransferase
MIP-1Macrophage inflammatory protein
miRNAMicro RNA
mRNAMessenger RNA
MVBMicro-vesicular Bodies
NIHDACHistone deacetylases
NSCLCNon-small cell lung cancer
PGE2Prostaglandin E2
PGFProstaglandin F2 alpha
piRNAsP-element induced wimpy testis (PIWI)-interacting RNA
pre-miRNAPrecursor micro RNA
pri-miRNAPrimary micro RNA
RIFRecurrent implantation failure
TEMTetraspanin-enriched microdomain
Th1T—helper cell type 1
UTRUntranslated region

References

  1. Oltenacu, P.; Broom, D. The impact of genetic selection for increased milk yield on the welfare of dairy cows. Anim. Welf. 2010, 19, 39–49. [Google Scholar]
  2. Garnsworthy, P.C.; Sinclair, K.D.; Webb, R. Integration of physiological mechanisms that influence fertility in dairy cows. Animal 2008, 2, 1144–1152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Formigoni, A.; Trevisi, E. Transition cow: Interaction with fertility. Vet. Res. Commun. 2003, 27 (Suppl. S1), 143–152. [Google Scholar] [CrossRef] [PubMed]
  4. McDougall, S.; Hussein, H.; Aberdein, D.; Buckle, K.; Roche, J.; Burke, C.; Mitchell, M.; Meier, S. Relationships between cytology, bacteriology and vaginal discharge scores and reproductive performance in dairy cattle. Theriogenology 2011, 76, 229–240. [Google Scholar] [CrossRef] [PubMed]
  5. Piccinini, R.; Binda, E.; Belotti, M.; Casirani, G.; Zecconi, A. The evaluation of non-specific immune status of heifers in field conditions during the periparturient period. Vet. Res. 2004, 35, 539–550. [Google Scholar] [CrossRef] [Green Version]
  6. Gilbert, R.O. Symposium review: Mechanisms of disruption of fertility by infectious diseases of the reproductive tract. J. Dairy Sci. 2019, 102, 3754–3765. [Google Scholar] [CrossRef] [Green Version]
  7. Britt, J.H. Enhanced reproduction and its economic implications. J. Dairy Sci. 1985, 68, 1585–1592. [Google Scholar] [CrossRef]
  8. Dubuc, J.; Duffield, T.F.; Leslie, K.E.; Walton, J.S.; Leblanc, S.J. Effects of postpartum uterine diseases on milk production and culling in dairy cows. J. Dairy Sci. 2011, 94, 1339–1346. [Google Scholar] [CrossRef]
  9. Koh, Y.Q.; Peiris, H.N.; Vaswani, K.; Almughlliq, F.B.; Meier, S.; Burke, C.R.; Roche, J.R.; Reed, C.B.; Mitchell, M.D. Exosomes from dairy cows of divergent fertility; Action on endometrial cells. J. Reprod. Immunol. 2020, 137, 102624. [Google Scholar] [CrossRef]
  10. Almughlliq, F.B.; Koh, Y.Q.; Peiris, H.N.; Vaswani, K.; Holland, O.; Meier, S.; Roche, J.R.; Burke, C.R.; Crookenden, M.A.; Arachchige, B.J.; et al. Circulating exosomes may identify biomarkers for cows at risk for metabolic dysfunction. Sci. Rep. 2019, 9, 13879. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Salomon, C.; Kobayashi, M.; Ashman, K.; Sobrevia, L.; Mitchell, M.D.; Rice, G.E. Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes. PLoS ONE 2013, 8, e79636. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Simpson, R.J.; Jensen, S.S.; Lim, J.W. Proteomic profiling of exosomes: Current perspectives. Proteomics 2008, 8, 4083–4099. [Google Scholar] [CrossRef]
  13. Simpson, R.J.; Lim, J.W.; Moritz, R.L.; Mathivanan, S. Exosomes: Proteomic insights and diagnostic potential. Expert Rev. Proteom. 2009, 6, 267–283. [Google Scholar] [CrossRef] [PubMed]
  14. Almughlliq, F.B.; Koh, Y.Q.; Peiris, H.N.; Vaswani, K.; McDougall, S.; Graham, E.M.; Burke, C.R.; Mitchell, M.D. Effect of exosomes from plasma of dairy cows with or without an infected uterus on prostaglandin production by endometrial cell lines. J. Dairy Sci. 2017, 100, 9143–9152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Koh, Y.Q.; Peiris, H.N.; Vaswani, K.; Almughlliq, F.B.; Meier, S.; Burke, C.R.; Roche, J.R.; Reed, C.B.; Arachchige, B.J.; Reed, S.; et al. Proteome profiling of exosomes derived from plasma of heifers with divergent genetic merit for fertility. J. Dairy Sci. 2018, 101, 6462–6473. [Google Scholar] [CrossRef] [PubMed]
  16. Valadi, H. Exosomes contain a selective number of mRNA and microRNA. Allergy 2007, 62, 372. [Google Scholar]
  17. Record, M.; Carayon, K.; Poirot, M.; Silvente-Poirot, S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim. Biophys. Acta 2014, 1841, 108–120. [Google Scholar] [CrossRef]
  18. Crookenden, M.A.; Walker, C.G.; Peiris, H.; Koh, Y.; Heiser, A.; Loor, J.J.; Moyes, K.M.; Murray, A.; Dukkipati, V.S.R.; Kay, J.K.; et al. Short communication: Proteins from circulating exosomes represent metabolic state in transition dairy cows. J. Dairy Sci. 2016, 99, 7661–7668. [Google Scholar] [CrossRef] [Green Version]
  19. Munagala, R.; Aqil, F.; Jeyabalan, J.; Gupta, R.C. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016, 371, 48–61. [Google Scholar] [CrossRef] [Green Version]
  20. Sheller-Miller, S.; Lei, J.; Saade, G.; Salomon, C.; Burd, I.; Menon, R. Feto-Maternal trafficking of exosomes in murine pregnancy models. Front. Pharmacol. 2016, 7, 432. [Google Scholar] [CrossRef] [Green Version]
  21. Pinedo, P.; Santos, J.E.P.; Chebel, R.C.; Galvão, K.N.; Schuenemann, G.M.; Bicalho, R.C.; Gilbert, R.O.; Rodriguez Zas, S.; Seabury, C.M.; Rosa, G.; et al. Early-lactation diseases and fertility in 2 seasons of calving across US dairy herds. J. Dairy Sci. 2020, 103, 10560–10576. [Google Scholar] [CrossRef] [PubMed]
  22. Bondurant, R.H. Inflammation in the bovine female reproductive tract. J. Anim. Sci. 1999, 77, 101–110. [Google Scholar] [CrossRef] [PubMed]
  23. Tizard, I.R. Hypersensitivity. In Veterinary Immunology: An Introduction; W. B. Saunders Co.: Philadelphia, PA, USA, 1996; pp. 343–401. [Google Scholar]
  24. Ribeiro, E.; Romulo Carvalho, M. Impact and mechanisms of inflammatory diseases on embryonic development and fertility in cattle. Anim. Reprod. 2017, 14, 589–600. [Google Scholar] [CrossRef]
  25. Sheldon, I.M.; Cronin, J.G.; Bromfield, J.J. Tolerance and innate immunity shape the development of postpartum uterine disease and the impact of endometritis in dairy cattle. Annu. Rev. Anim. Biosci. 2019, 7, 361–384. [Google Scholar] [CrossRef] [Green Version]
  26. Nie, Z.-W.; Niu, Y.-J.; Zhou, W.; Kim, J.-Y.; Ock, S.A.; Cui, X.-S. Thiamethoxam induces meiotic arrest and reduces the quality of oocytes in cattle. Toxicol. Vitr. 2019, 61, 104635. [Google Scholar] [CrossRef]
  27. Chastant, S.; Saint-Dizier, M. Inflammation: Friend or foe of bovine reproduction? Anim. Reprod. 2019, 16, 539–547. [Google Scholar] [CrossRef] [Green Version]
  28. Chargaff, E.; West, R. The biological significance of the thromboplastic protein of blood. J. Biol. Chem. 1946, 166, 189–197. [Google Scholar]
  29. Wolf, P. The nature and significance of platelet products in human plasma. Br. J. Haematol. 1967, 13, 269–288. [Google Scholar] [CrossRef]
  30. Yellon, D.M.; Davidson, S.M. Exosomes: Nanoparticles involved in cardioprotection? Circ. Res. 2014, 114, 325–332. [Google Scholar] [CrossRef]
  31. Mitchell, M.D.; Scholz-Romero, K.; Reed, S.; Peiris, H.N.; Koh, Y.Q.; Meier, S.; Walker, C.G.; Burke, C.R.; Roche, J.R.; Rice, G.; et al. Plasma exosome profiles from dairy cows with divergent fertility phenotypes. J. Dairy Sci. 2016, 99, 7590–7601. [Google Scholar] [CrossRef] [Green Version]
  32. Almughlliq, F.B.; Koh, Y.Q.; Peiris, H.N.; Vaswani, K.; McDougall, S.; Graham, E.M.; Burke, C.R.; Arachchige, B.J.; Reed, S.; Mitchell, M.D. Proteomic content of circulating exosomes in dairy cows with or without uterine infection. Theriogenology 2018, 114, 173–179. [Google Scholar] [CrossRef] [PubMed]
  33. Zhang, Y.; Liu, Y.; Liu, H.; Tang, W.H. Exosomes: Biogenesis, biologic function and clinical potential. Cell Biosci. 2019, 9, 19. [Google Scholar] [CrossRef] [PubMed]
  34. Muller, G.; Jung, C.; Wied, S.; Biemer-Daub, G.; Frick, W. Transfer of the glycosylphosphatidylinositol-anchored 5’-nucleotidase CD73 from adiposomes into rat adipocytes stimulates lipid synthesis. Br. J. Pharm. 2010, 160, 878–891. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Laulagnier, K.; Motta, C.; Hamdi, S.; Roy, S.; Fauvelle, F.; Pageaux, J.F.; Kobayashi, T.; Salles, J.P.; Perret, B.; Bonnerot, C.; et al. Mast cell- and dendritic cell-derived display a specific lipid composition and an unusual membrane organization. Biochem. J. 2004, 380, 161–171. [Google Scholar] [CrossRef] [PubMed]
  36. Pieters, B.C.; Arntz, O.J.; Bennink, M.B.; Broeren, M.G.; van Caam, A.P.; Koenders, M.I.; van Lent, P.L.; van den Berg, W.B.; de Vries, M.; van der Kraan, P.M.; et al. Commercial cow milk contains physically stable extracellular vesicles expressing immunoregulatory TGF-beta. PLoS ONE 2015, 10, e0121123. [Google Scholar] [CrossRef]
  37. Melnik, B.C.; Kakulas, F.; Geddes, D.T.; Hartmann, P.E.; John, S.M.; Carrera-Bastos, P.; Cordain, L.; Schmitz, G. Milk miRNAs: Simple nutrients or systemic functional regulators? Nutr. Metab. 2016, 13, 42. [Google Scholar] [CrossRef] [Green Version]
  38. Minciacchi, V.R.; Freeman, M.R.; Di Vizio, D. Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol 2015, 40, 41–51. [Google Scholar] [CrossRef] [Green Version]
  39. Record, M. Intercellular communication by exosomes in placenta: A possible role in cell fusion? Placenta 2014, 35, 297–302. [Google Scholar] [CrossRef]
  40. Henne, W.M.; Buchkovich, N.J.; Emr, S.D. The ESCRT pathway. Dev. Cell 2011, 21, 77–91. [Google Scholar] [CrossRef] [Green Version]
  41. Hurley, J.H. ESCRTs are everywhere. EMBO J. 2015, 34, 2398–2407. [Google Scholar] [CrossRef] [Green Version]
  42. Villarroya-Beltri, C.; Baixauli, F.; Gutierrez-Vazquez, C.; Sanchez-Madrid, F.; Mittelbrunn, M. Sorting it out: Regulation of exosome loading. Semin. Cancer Biol. 2014, 28, 3–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Airola, M.V.; Hannun, Y.A. Sphingolipid metabolism and neutral sphingomyelinases. Handb. Exp. Pharm. 2013, 57–76. [Google Scholar] [CrossRef] [Green Version]
  44. Perez-Hernandez, D.; Gutierrez-Vazquez, C.; Jorge, I.; Lopez-Martin, S.; Ursa, A.; Sanchez-Madrid, F.; Vazquez, J.; Yanez-Mo, M. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol Chem 2013, 288, 11649–11661. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Van den Boorn, J.G.; Dassler, J.; Coch, C.; Schlee, M.; Hartmann, G. Exosomes as nucleic acid nanocarriers. Adv. Drug Deliv. Rev. 2013, 65, 331–335. [Google Scholar] [CrossRef]
  46. Camussi, G.; Deregibus, M.C.; Bruno, S.; Cantaluppi, V.; Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010, 78, 838–848. [Google Scholar] [CrossRef] [Green Version]
  47. Simons, M.; Raposo, G. Exosomes--vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 2009, 21, 575–581. [Google Scholar] [CrossRef]
  48. Tian, T.; Wang, Y.; Wang, H.; Zhu, Z.; Xiao, Z. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J. Cell Biochem. 2010, 111, 488–496. [Google Scholar] [CrossRef]
  49. Greening, D.W.; Gopal, S.K.; Xu, R.; Simpson, R.J.; Chen, W. Exosomes and their roles in immune regulation and cancer. Semin. Cell Dev. Biol. 2015, 40, 72–81. [Google Scholar] [CrossRef]
  50. Gangoda, L.; Boukouris, S.; Liem, M.; Kalra, H.; Mathivanan, S. Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic? Proteomics 2015, 15, 260–271. [Google Scholar] [CrossRef] [Green Version]
  51. Mittelbrunn, M.; Gutierrez-Vazquez, C.; Villarroya-Beltri, C.; Gonzalez, S.; Sanchez-Cabo, F.; Gonzalez, M.A.; Bernad, A.; Sanchez-Madrid, F. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun 2011, 2, 282. [Google Scholar] [CrossRef] [Green Version]
  52. Khalyfa, A.; Gozal, D. Exosomal miRNAs as potential biomarkers of cardiovascular risk in children. J. Transl. Med. 2014, 12, 162. [Google Scholar] [CrossRef] [Green Version]
  53. Record, M.; Poirot, M.; Silvente-Poirot, S. Emerging concepts on the role of exosomes in lipid metabolic diseases. Biochimie 2014, 96, 67–74. [Google Scholar] [CrossRef]
  54. Salem, K.Z.; Moschetta, M.; Sacco, A.; Imberti, L.; Rossi, G.; Ghobrial, I.M.; Manier, S.; Roccaro, A.M. Exosomes in tumor angiogenesis. Methods Mol. Biol. 2016, 1464, 25–34. [Google Scholar] [CrossRef]
  55. Howitt, J.; Hill, A.F. Exosomes in the pathology of neurodegenerative diseases. J. Biol. Chem. 2016, 291, 26589–26597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Lasser, C.; O’Neil, S.E.; Shelke, G.V.; Sihlbom, C.; Hansson, S.F.; Gho, Y.S.; Lundback, B.; Lotvall, J. Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation. J. Transl. Med. 2016, 14, 181. [Google Scholar] [CrossRef] [Green Version]
  57. Raposo, G.; Nijman, H.W.; Stoorvogel, W.; Liejendekker, R.; Harding, C.V.; Melief, C.J.; Geuze, H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183, 1161–1172. [Google Scholar] [CrossRef]
  58. Okoye, I.S.; Coomes, S.M.; Pelly, V.S.; Czieso, S.; Papayannopoulos, V.; Tolmachova, T.; Seabra, M.C.; Wilson, M.S. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 2014, 41, 503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Smyth, L.A.; Ratnasothy, K.; Tsang, J.Y.; Boardman, D.; Warley, A.; Lechler, R.; Lombardi, G. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur. J. Immunol. 2013, 43, 2430–2440. [Google Scholar] [CrossRef]
  60. Clayton, A.; Al-Taei, S.; Webber, J.; Mason, M.D.; Tabi, Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. 2011, 187, 676–683. [Google Scholar] [CrossRef]
  61. Zitvogel, L.; Regnault, A.; Lozier, A.; Wolfers, J.; Flament, C.; Tenza, D.; Ricciardi-Castagnoli, P.; Raposo, G.; Amigorena, S. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 1998, 4, 594–600. [Google Scholar] [CrossRef]
  62. Zhang, H.; Xie, Y.; Li, W.; Chibbar, R.; Xiong, S.; Xiang, J. CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity. Cell Mol. Immunol. 2011, 8, 23–30. [Google Scholar] [CrossRef] [PubMed]
  63. Cressatti, M.; Galindez, J.M.; Juwara, L.; Orlovetskie, N.; Velly, A.M.; Eintracht, S.; Liberman, A.; Gornitsky, M.; Schipper, H.M. Characterization and heme oxygenase-1 content of extracellular vesicles in human biofluids. J. Neurochem. 2020. [Google Scholar] [CrossRef] [PubMed]
  64. Zhou, W.; Tahir, F.; Wang, J.C.; Woodson, M.; Sherman, M.B.; Karim, S.; Neelakanta, G.; Sultana, H. Discovery of exosomes from tick saliva and salivary glands reveals therapeutic roles for CXCL12 and IL-8 in wound healing at the tick-human skin interface. Front. Cell Dev. Biol 2020, 8, 554. [Google Scholar] [CrossRef] [PubMed]
  65. Yokoyama, S.; Takeuchi, A.; Yamaguchi, S.; Mitani, Y.; Watanabe, T.; Matsuda, K.; Hotta, T.; Shively, J.E.; Yamaue, H. Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-measurement by ELISA. PLoS ONE 2017, 12, e0183337. [Google Scholar] [CrossRef]
  66. Palacios, A.; Sampedro, L.; Sevilla, I.A.; Molina, E.; Gil, D.; Azkargorta, M.; Elortza, F.; Garrido, J.M.; Anguita, J.; Prados-Rosales, R. Mycobacterium tuberculosis extracellular vesicle-associated lipoprotein LpqH as a potential biomarker to distinguish paratuberculosis infection or vaccination from tuberculosis infection. BMC Vet. Res. 2019, 15, 188. [Google Scholar] [CrossRef] [Green Version]
  67. Banliat, C.; Le Bourhis, D.; Bernardi, O.; Tomas, D.; Labas, V.; Salvetti, P.; Guyonnet, B.; Mermillod, P.; Saint-Dizier, M. Oviduct fluid extracellular vesicles change the phospholipid composition of bovine embryos developed in vitro. Int. J. Mol. Sci. 2020, 21, 5326. [Google Scholar] [CrossRef]
  68. Sato, M.; Suzuki, T.; Kawano, M.; Tamura, M. Circulating osteocyte-derived exosomes contain miRNAs which are enriched in exosomes from MLO-Y4 cells. Biomed. Rep. 2017, 6, 223–231. [Google Scholar] [CrossRef]
  69. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659. [Google Scholar] [CrossRef] [Green Version]
  70. Ishikawa, H.; Rahman, M.M.; Yamauchi, M.; Takashima, S.; Wakihara, Y.; Kamatari, Y.O.; Shimizu, K.; Okada, A.; Inoshima, Y. mRNA profile in milk extracellular vesicles from bovine leukemia virus-infected cattle. Viruses 2020, 12, 669. [Google Scholar] [CrossRef]
  71. Chen, T.; Xi, Q.-Y.; Sun, J.-J.; Ye, R.-S.; Cheng, X.; Sun, R.-P.; Wang, S.-B.; Shu, G.; Wang, L.-N.; Zhu, X.-T.; et al. Revelation of mRNAs and proteins in porcine milk exosomes by transcriptomic and proteomic analysis. BMC Vet. Res. 2017, 13, 101. [Google Scholar] [CrossRef]
  72. Izumi, H.; Tsuda, M.; Sato, Y.; Kosaka, N.; Ochiya, T.; Iwamoto, H.; Namba, K.; Takeda, Y. Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J. Dairy Sci. 2015, 98, 2920–2933. [Google Scholar] [CrossRef] [Green Version]
  73. Kashi, K.; Henderson, L.; Bonetti, A.; Carninci, P. Discovery and functional analysis of lncRNAs: Methodologies to investigate an uncharacterized transcriptome. Biochim Biophys Acta 2016, 1859, 3–15. [Google Scholar] [CrossRef] [Green Version]
  74. Chavatte-Palmer, P.; Velazquez, M.A.; Jammes, H.; Duranthon, V. Review: Epigenetics, developmental programming and nutrition in herbivores. Animal 2018, 12, s363–s371. [Google Scholar] [CrossRef] [Green Version]
  75. Zheng, R.; Du, M.; Wang, X.; Xu, W.; Liang, J.; Wang, W.; Lv, Q.; Qin, C.; Chu, H.; Wang, M.; et al. Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol. Cancer 2018, 17, 143. [Google Scholar] [CrossRef]
  76. Chen, L.; Zhu, Q.H.; Kaufmann, K. Long non-coding RNAs in plants: Emerging modulators of gene activity in development and stress responses. Planta 2020, 252, 92. [Google Scholar] [CrossRef]
  77. Panni, S.; Lovering, R.C.; Porras, P.; Orchard, S. Non-coding RNA regulatory networks. Biochim. Biophys. Acta. Gene. Regul. Mech. 2020, 1863, 194417. [Google Scholar] [CrossRef]
  78. Zeng, B.; Chen, T.; Xie, M.-Y.; Luo, J.-Y.; He, J.-J.; Xi, Q.-Y.; Sun, J.-J.; Zhang, Y.-L. Exploration of long noncoding RNA in bovine milk exosomes and their stability during digestion in vitro. J. Dairy Sci. 2019, 102, 6726–6737. [Google Scholar] [CrossRef]
  79. Ambros, V. The functions of animal microRNAs. Nature 2004, 431, 350–355. [Google Scholar] [CrossRef]
  80. He, L.; Hannon, G.J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5, 522–531. [Google Scholar] [CrossRef]
  81. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436, 214–220. [Google Scholar] [CrossRef]
  82. He, L.; Thomson, J.M.; Hemann, M.T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S.W.; Hannon, G.J.; et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435, 828–833. [Google Scholar] [CrossRef] [PubMed]
  83. Chen, C.Z.; Li, L.; Lodish, H.F.; Bartel, D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303, 83–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Poy, M.N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Ma, X.; Macdonald, P.E.; Pfeffer, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432, 226–230. [Google Scholar] [CrossRef] [PubMed]
  85. Zhou, Q.; Li, M.; Wang, X.; Li, Q.; Wang, T.; Zhu, Q.; Zhou, X.; Wang, X.; Gao, X.; Li, X. Immune-related microRNAs are abundant in breast milk exosomes. Int. J. Biol. Sci. 2012, 8, 118–123. [Google Scholar] [CrossRef] [PubMed]
  86. Benmoussa, A.; Laugier, J.; Beauparlant, C.J.; Lambert, M.; Droit, A.; Provost, P. Complexity of the microRNA transcriptome of cow milk and milk-derived extracellular vesicles isolated via differential ultracentrifugation. J. Dairy Sci. 2020, 103, 16–29. [Google Scholar] [CrossRef]
  87. Hata, T.; Murakami, K.; Nakatani, H.; Yamamoto, Y.; Matsuda, T.; Aoki, N. Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. Biochem. Biophys. Res. Commun. 2010, 396, 528–533. [Google Scholar] [CrossRef]
  88. Howard, K.M.; Jati Kusuma, R.; Baier, S.R.; Friemel, T.; Markham, L.; Vanamala, J.; Zempleni, J. Loss of miRNAs during processing and storage of cow’s (Bos taurus) milk. J. Agric. Food Chem. 2015, 63, 588–592. [Google Scholar] [CrossRef] [Green Version]
  89. Sun, Q.; Chen, X.; Yu, J.; Zen, K.; Zhang, C.Y.; Li, L. Immune modulatory function of abundant immune-related microRNAs in microvesicles from bovine colostrum. Protein Cell 2013, 4, 197–210. [Google Scholar] [CrossRef] [Green Version]
  90. Klopfleisch, R.; Weiss, A.T.; Gruber, A.D. Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol. Histopathol. 2011, 26, 797–810. [Google Scholar] [CrossRef]
  91. Streichert, T.; Otto, B.; Lehmann, U. MicroRNA expression profiling in archival tissue specimens: Methods and data processing. Mol. Biotechnol. 2012, 50, 159–169. [Google Scholar] [CrossRef]
  92. Yu, S.; Zhao, Z.; Sun, L.; Li, P. Fermentation results in quantitative changes in milk-derived exosomes and different effects on cell growth and survival. J. Agric. Food Chem. 2017, 65, 1220–1228. [Google Scholar] [CrossRef] [PubMed]
  93. Chen, X.; Liang, H.; Zhang, J.; Zen, K.; Zhang, C.Y. Horizontal transfer of microRNAs: Molecular mechanisms and clinical applications. Protein Cell 2012, 3, 28–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Wang, W.T.; Zhao, Y.N.; Han, B.W.; Hong, S.J.; Chen, Y.Q. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J. Clin. Endocrinol. Metab. 2013, 98, 281–289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Jia, S.Z.; Yang, Y.; Lang, J.; Sun, P.; Leng, J. Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis. Hum. Reprod. 2013, 28, 322–330. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Mitchell, M.D.; Crookenden, M.A.; Vaswani, K.; Roche, J.R.; Peiris, H.N. The frontiers of biomedical science and its application to animal science in addressing the major challenges facing Australasian dairy farming. Anim. Prod. Sci. 2020, 60, 1–9. [Google Scholar] [CrossRef] [Green Version]
  97. Laudanski, P.; Charkiewicz, R.; Kuzmicki, M.; Szamatowicz, J.; Charkiewicz, A.; Niklinski, J. MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis. Reprod. Biol. Endocrinol. 2013, 11, 78. [Google Scholar] [CrossRef] [Green Version]
  98. Zhao, L.; Gu, C.; Ye, M.; Zhang, Z.; Li, L.; Fan, W.; Meng, Y. Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis. Reprod. Biol. Endocrinol. 2018, 16, 4. [Google Scholar] [CrossRef]
  99. Maier, T.; Güell, M.; Serrano, L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009, 583, 3966–3973. [Google Scholar] [CrossRef] [Green Version]
  100. Shebl, F.M.; Pinto, L.A.; García-Piñeres, A.; Lempicki, R.; Williams, M.; Harro, C.; Hildesheim, A. Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particles. Cancer Epidemiol. Biomark. Prev. 2010, 19, 978. [Google Scholar] [CrossRef] [Green Version]
  101. Rametse, C.L.; Adefuye, A.O.; Olivier, A.J.; Curry, L.; Gamieldien, H.; Burgers, W.A.; Lewis, D.A.; Williamson, A.-L.; Katz, A.A.; Passmore, J.-A.S. Inflammatory cytokine profiles of semen influence cytokine responses of cervicovaginal epithelial cells. Front. Immunol. 2018, 9. [Google Scholar] [CrossRef]
  102. Sheldon, I.M.; James, G.C.; Gareth, D.H.; Christoph, G.; Wolfgang, H.; Dominik, S.; John, J.B.; Akio, M.; Chrys, F.; Hilary, D. Innate immunity and inflammation of the bovine female reproductive tract in health and disease. Reproduction 2014, 148, R41–R51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Kang, Y.J.; Lees, M.; Matthews, L.C.; Kimber, S.J.; Forbes, K.; Aplin, J.D. MiR-145 suppresses embryo-epithelial juxtacrine communication at implantation by modulating maternal IGF1R. J. Cell Sci. 2015, 128, 804–814. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Inyawilert, W.; Fu, T.Y.; Lin, C.T.; Tang, P.C. MicroRNA-199a mediates mucin 1 expression in mouse uterus during implantation. Reprod. Fertil. Dev. 2014, 26, 653–664. [Google Scholar] [CrossRef] [PubMed]
  105. Wang, X.; Tian, F.; Chen, C.; Feng, Y.; Sheng, X.; Guo, Y.; Ni, H. Exosome-derived uterine microRNAs isolated from cows with endometritis impede blastocyst development. Reprod. Biol. 2019, 19, 204–209. [Google Scholar] [CrossRef] [PubMed]
  106. Sohel, M.M.; Hoelker, M.; Noferesti, S.S.; Salilew-Wondim, D.; Tholen, E.; Looft, C.; Rings, F.; Uddin, M.J.; Spencer, T.E.; Schellander, K.; et al. Exosomal and non-exosomal transport of extra-cellular micrornas in follicular fluid: Implications for bovine oocyte developmental competence. PLoS ONE 2013, 8, e78505. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Sheldon, I.M.; Williams, E.J.; Miller, A.N.A.; Nash, D.M.; Herath, S. Uterine diseases in cattle after parturition. Vet. J. 2008, 176, 115–121. [Google Scholar] [CrossRef]
  108. Wang, X.; Yao, X.; Xie, T.; Chang, Z.; Guo, Y.; Ni, H. Exosome-derived uterine miR-218 isolated from cows with endometritis regulates the release of cytokines and chemokines. Microb. Biotechnol. 2020, 13, 1103–1117. [Google Scholar] [CrossRef] [Green Version]
  109. Gao, P.; Wang, D.; Liu, M.; Chen, S.; Yang, Z.; Zhang, J.; Wang, H.; Niu, Y.; Wang, W.; Yang, J.; et al. DNA methylation-mediated repression of exosomal miR-652-5p expression promotes oesophageal squamous cell carcinoma aggressiveness by targeting PARG and VEGF pathways. PLoS Genet. 2020, 16, e1008592. [Google Scholar] [CrossRef]
  110. El Andaloussi, S.; Mäger, I.; Breakefield, X.O.; Wood, M.J.A. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat. Reviews. Drug Discov. 2013, 12, 347–357. [Google Scholar] [CrossRef]
  111. Qian, Z.; Shen, Q.; Yang, X.; Qiu, Y.; Zhang, W. The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment. BioMed Res. Int. 2015, 2015, 649161. [Google Scholar] [CrossRef] [Green Version]
  112. Yamamoto, H.; Watanabe, Y.; Oikawa, R.; Morita, R.; Yoshida, Y.; Maehata, T.; Yasuda, H.; Itoh, F. BARHL2 methylation using gastric wash dna or gastric juice exosomal dna is a useful marker for early detection of gastric cancer in anh. pylori-independent manner. Clin. Transl. Gastroenterol. 2016, 7, e184. [Google Scholar] [CrossRef] [PubMed]
  113. Zhu, X.; You, Y.; Li, Q.; Zeng, C.; Fu, F.; Guo, A.; Zhang, H.; Zou, P.; Zhong, Z.; Wang, H.; et al. BCR-ABL1–positive microvesicles transform normal hematopoietic transplants through genomic instability: Implications for donor cell leukemia. Leukemia 2014, 28, 1666–1675. [Google Scholar] [CrossRef] [PubMed]
  114. Shao, H.; Chung, J.; Lee, K.; Balaj, L.; Min, C.; Carter, B.S.; Hochberg, F.H.; Breakefield, X.O.; Lee, H.; Weissleder, R. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat. Commun. 2015, 6, 6999. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  115. Rajender, S.; Avery, K.; Agarwal, A. Epigenetics, spermatogenesis and male infertility. Mutat. Res. Rev. Mutat. Res. 2011, 727, 62–71. [Google Scholar] [CrossRef] [PubMed]
  116. Pallotta, M.M.; Barbato, V.; Pinton, A.; Acloque, H.; Gualtieri, R.; Talevi, R.; Jammes, H.; Capriglione, T. In vitro exposure to CPF affects bovine sperm epigenetic gene methylation pattern and the ability of sperm to support fertilization and embryo development. Environ. Mol. Mutagen. 2019, 60, 85–95. [Google Scholar] [CrossRef] [Green Version]
  117. Fang, L.; Zhou, Y.; Liu, S.; Jiang, J.; Bickhart, D.M.; Null, D.J.; Li, B.; Schroeder, S.G.; Rosen, B.D.; Cole, J.B.; et al. Comparative analyses of sperm DNA methylomes among human, mouse and cattle provide insights into epigenomic evolution and complex traits. Epigenetics 2019, 14, 260–276. [Google Scholar] [CrossRef]
  118. Ahlawat, S.; Sharma, R.; Arora, R.; Kumari, N.; Mishra, A.K.; Tantia, M.S. Promoter methylation and expression analysis of Bvh gene in bulls with varying semen motility parameters. Theriogenology 2019, 125, 152–156. [Google Scholar] [CrossRef] [PubMed]
  119. Zhang, G.-W.; Wang, L.; Chen, H.; Guan, J.; Wu, Y.; Zhao, J.; Luo, Z.; Huang, W.; Zuo, F. Promoter hypermethylation of PIWI/piRNA pathway genes associated with diminished pachytene piRNA production in bovine hybrid male sterility. Epigenetics 2020, 15, 914–931. [Google Scholar] [CrossRef] [PubMed]
  120. Capra, E.; Lazzari, B.; Turri, F.; Cremonesi, P.; Portela, A.M.R.; Ajmone-Marsan, P.; Stella, A.; Pizzi, F. Epigenetic analysis of high and low motile sperm populations reveals methylation variation in satellite regions within the pericentromeric position and in genes functionally related to sperm DNA organization and maintenance in Bos taurus. BMC Genom. 2019, 20, 940. [Google Scholar] [CrossRef] [PubMed]
  121. Wu, C.; Sirard, M.A. Parental Effects on Epigenetic Programming in Gametes and Embryos of Dairy Cows. Front. Genet. 2020, 11, 557846. [Google Scholar] [CrossRef]
  122. Wang, Y.; Wang, Y.; Wang, Y.; Zhang, Y. Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data. Sci. Rep. 2020, 10, 8575. [Google Scholar] [CrossRef] [PubMed]
  123. Sharma, A. Bioinformatic analysis revealing association of exosomal mRNAs and proteins in epigenetic inheritance. J. Theor. Biol. 2014, 357, 143–149. [Google Scholar] [CrossRef] [PubMed]
  124. Schiera, G.; Di Liegro, C.M.; Saladino, P.; Pitti, R.; Savettieri, G.; Proia, P.; Di Liegro, I. Oligodendroglioma cells synthesize the differentiation-specific linker histone H1˚ and release it into the extracellular environment through shed vesicles. Int. J. Oncol. 2013, 43, 1771–1776. [Google Scholar] [CrossRef] [PubMed]
  125. Kusmartsev, S.; Gabrilovich, D.I. Inhibition of myeloid cell differentiation in cancer: The role of reactive oxygen species. J. Leukoc. Biol. 2003, 74, 186–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  126. Ugur, M.R.; Kutchy, N.A.; Menezes, E.B.D.; Ul-Husna, A.; Haynes, B.P.; Uzun, A.; Kaya, A.; Topper, E.; Moura, A.; Memili, E. Retained acetylated histone four in bull sperm associated with fertility. Front. Vet. Sci. 2019, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  127. Hundertmark, T.; Gärtner, S.M.K.; Rathke, C.; Renkawitz-Pohl, R. Nejire/dCBP-mediated histone H3 acetylation during spermatogenesis is essential for male fertility in Drosophila melanogaster. PLoS ONE 2018, 13, e0203622. [Google Scholar] [CrossRef]
  128. Kutchy, N.A.; Menezes, E.S.B.; Chiappetta, A.; Tan, W.; Wills, R.W.; Kaya, A.; Topper, E.; Moura, A.A.; Perkins, A.D.; Memili, E. Acetylation and methylation of sperm histone 3 lysine 27 (H3K27ac and H3K27me3) are associated with bull fertility. Andrologia 2018, 50. [Google Scholar] [CrossRef]
  129. Sangalli, J.R.; Sampaio, R.V.; Del Collado, M.; da Silveira, J.C.; De Bem, T.H.C.; Perecin, F.; Smith, L.C.; Meirelles, F.V. Metabolic gene expression and epigenetic effects of the ketone body β-hydroxybutyrate on H3K9ac in bovine cells, oocytes and embryos. Sci. Rep. 2018, 8, 13766. [Google Scholar] [CrossRef] [Green Version]
  130. Zhang, J.L.; Yuan, X.B.; Chen, S.J.; Chen, H.H.; Xu, N.; Xue, W.H.; Fu, S.J.; Zhang, C.X.; Xu, H.J. The histone deacetylase NlHDAC1 regulates both female and male fertility in the brown planthopper, Nilaparvata lugens. Open Biol. 2018, 8, 180158. [Google Scholar] [CrossRef] [Green Version]
  131. Luense, L.J.; Donahue, G.; Lin-Shiao, E.; Rangel, R.; Weller, A.H.; Bartolomei, M.S.; Berger, S.L. Gcn5-Mediated Histone Acetylation Governs Nucleosome Dynamics in Spermiogenesis. Dev. Cell 2019, 51, 745–758.e746. [Google Scholar] [CrossRef]
  132. Wu, L.; Wei, Y.; Li, H.; Li, W.; Gu, C.; Sun, J.; Xia, H.; Zhang, J.; Chen, F.; Liu, Q. The ubiquitination and acetylation of histones are associated with male reproductive disorders induced by chronic exposure to arsenite. Toxicol. Appl. Pharmacol. 2020, 408, 115253. [Google Scholar] [CrossRef] [PubMed]
  133. González, B.; Pantoja, C.R.G.; Sosa, M.H.; Vitullo, A.D.; Bisagno, V.; González, C.R. Cocaine alters the mouse testicular epigenome with direct impact on histone acetylation and DNA methylation marks. Reprod. Biomed. Online 2018, 37, 269–278. [Google Scholar] [CrossRef] [PubMed]
  134. Maciel, V.L., Jr.; Tamashiro, L.K.; Bertolla, R.P. Post-translational modifications of seminal proteins and their importance in male fertility potential. Expert Rev. Proteom. 2019, 16, 941–950. [Google Scholar] [CrossRef] [PubMed]
  135. Schon, S.B.; Luense, L.J.; Wang, X.; Bartolomei, M.S.; Coutifaris, C.; Garcia, B.A.; Berger, S.L. Histone modification signatures in human sperm distinguish clinical abnormalities. J. Assist. Reprod. Genet. 2019, 36, 267–275. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Exosome biosynthesis and miRNA Communication between cells a—Translation of primary miRNA (Pri-miRNA) from DNA; b—Cleavage of pri-miRNA to precursor miRNA(Pre-miRNA) by microprocessor complex including Drosha; c—Exportation of Pre-miRNA to the cytoplasm by Exportin 5(EXP-5); d—Pre-miRNA processing into miRNA duplexes using Dicer; e—Duplex unwinds to produce mature miRNA; f—miRNA engulf into endosomes; g—Few miRNA’s contribute to target mRNA silencing in the Donor cell; h—Endosomes engulfed miRNA; i—Micro-vesicular Bodies (MVB) release Intraluminal Vesicles (ILV) fuse with the plasma membrane j—Exosomes carrying miRNAs; k—Exosome entry to recipient cell via receptor-mediated endocytosis; l—Entrance of exosomes via Phagocytosis/Pinocytosis; m—Exosome entry via Direct membrane fusion; n—Formation of Endosome in the recipient cell and then exosomal miRNA release into the cytoplasm.
Figure 1. Exosome biosynthesis and miRNA Communication between cells a—Translation of primary miRNA (Pri-miRNA) from DNA; b—Cleavage of pri-miRNA to precursor miRNA(Pre-miRNA) by microprocessor complex including Drosha; c—Exportation of Pre-miRNA to the cytoplasm by Exportin 5(EXP-5); d—Pre-miRNA processing into miRNA duplexes using Dicer; e—Duplex unwinds to produce mature miRNA; f—miRNA engulf into endosomes; g—Few miRNA’s contribute to target mRNA silencing in the Donor cell; h—Endosomes engulfed miRNA; i—Micro-vesicular Bodies (MVB) release Intraluminal Vesicles (ILV) fuse with the plasma membrane j—Exosomes carrying miRNAs; k—Exosome entry to recipient cell via receptor-mediated endocytosis; l—Entrance of exosomes via Phagocytosis/Pinocytosis; m—Exosome entry via Direct membrane fusion; n—Formation of Endosome in the recipient cell and then exosomal miRNA release into the cytoplasm.
Ijms 21 09106 g001
Figure 2. Differential expression of cytokines in bovine endometrial cells (a) Increased relative fold expression of prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF), interleukin 1 alpha (IL1α), (C-X-C motif) ligand 8/interleukin-8 (CXCL8/IL8) in low fertile exosome loaded cells. (b) Decreased relative fold expression of (C-X-C motif) ligand 9 (CXCL9), (C-X-C motif) ligand 10 (CXCL10) and interleukin 4 (IL-4). Differences of P < 0.05 are considered statistically significant between sample groups denoted by *. Adapted by experimental data published in Koh et al., 2020 [9].
Figure 2. Differential expression of cytokines in bovine endometrial cells (a) Increased relative fold expression of prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF), interleukin 1 alpha (IL1α), (C-X-C motif) ligand 8/interleukin-8 (CXCL8/IL8) in low fertile exosome loaded cells. (b) Decreased relative fold expression of (C-X-C motif) ligand 9 (CXCL9), (C-X-C motif) ligand 10 (CXCL10) and interleukin 4 (IL-4). Differences of P < 0.05 are considered statistically significant between sample groups denoted by *. Adapted by experimental data published in Koh et al., 2020 [9].
Ijms 21 09106 g002
Figure 3. Epigenetic regulation of bovine uterine inflammatory diseases. (A). Macroscopic view—Comparison of a healthy and endometritis infected bovine reproductive system Endometritis is defined as a localized infection of the uterus lining [107]. (B). Microscopic view—Transcribed miRNA precursor (pre-miRNA) transfer to the cellular cytoplasm before mature miRNA targets the 3′ untranslated region (UTR) of specific mRNA. The inactive complex of (miRNA-mRNA) repress the translation process and the fate of mRNA is to be degraded. This may result in inflammatory diseases such as endometritis and poor fertility. For example, miR-218 has shown to be involved in the pathogenesis of bovine endometritis by inhibiting the activating mRNA of macrophage inflammatory protein (Mip-1) chemokine [108].
Figure 3. Epigenetic regulation of bovine uterine inflammatory diseases. (A). Macroscopic view—Comparison of a healthy and endometritis infected bovine reproductive system Endometritis is defined as a localized infection of the uterus lining [107]. (B). Microscopic view—Transcribed miRNA precursor (pre-miRNA) transfer to the cellular cytoplasm before mature miRNA targets the 3′ untranslated region (UTR) of specific mRNA. The inactive complex of (miRNA-mRNA) repress the translation process and the fate of mRNA is to be degraded. This may result in inflammatory diseases such as endometritis and poor fertility. For example, miR-218 has shown to be involved in the pathogenesis of bovine endometritis by inhibiting the activating mRNA of macrophage inflammatory protein (Mip-1) chemokine [108].
Ijms 21 09106 g003
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Abeysinghe, P.; Turner, N.; Morean Garcia, I.; Mosaad, E.; Peiris, H.N.; Mitchell, M.D. The Role of Exosomal Epigenetic Modifiers in Cell Communication and Fertility of Dairy Cows. Int. J. Mol. Sci. 2020, 21, 9106. https://doi.org/10.3390/ijms21239106

AMA Style

Abeysinghe P, Turner N, Morean Garcia I, Mosaad E, Peiris HN, Mitchell MD. The Role of Exosomal Epigenetic Modifiers in Cell Communication and Fertility of Dairy Cows. International Journal of Molecular Sciences. 2020; 21(23):9106. https://doi.org/10.3390/ijms21239106

Chicago/Turabian Style

Abeysinghe, Pevindu, Natalie Turner, Isabella Morean Garcia, Eman Mosaad, Hassendrini N. Peiris, and Murray D. Mitchell. 2020. "The Role of Exosomal Epigenetic Modifiers in Cell Communication and Fertility of Dairy Cows" International Journal of Molecular Sciences 21, no. 23: 9106. https://doi.org/10.3390/ijms21239106

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop